Teiji Takechi
Tokushima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Lineage of drug discovery research on fluorinated pyrimidines: chronicle of the achievements accomplished by Professor Setsuro Fujii.
Journal: International journal of clinical oncology
Published: February 28, 2023
Erratum: Trifluridine/tipiracil increases survival rates in peritoneal dissemination mouse models of human colorectal and gastric cancer.
Journal: Oncology letters
Published: May 14, 2021
Estrogen Down-regulator Fulvestrant Potentiates Antitumor Activity of Fluoropyrimidine in Estrogen-responsive MCF-7 Human Breast Cancer Cells.
Journal: In vivo (Athens, Greece)
Published: May 20, 2019
CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure.
Journal: Scientific reports
Published: February 19, 2019
Effective Sequential Combined Chemotherapy with Trifluridine/Tipiracil and Regorafenib in Human Colorectal Cancer Cells.
Journal: International journal of molecular sciences
Published: August 17, 2018
Improved chemoradiation treatment using trifluridine in human colorectal cancer cells in vitro.
Journal: Biochemical and biophysical research communications
Published: October 03, 2017
Synergistic anticancer activity of a novel oral chemotherapeutic agent containing trifluridine and tipiracil in combination with anti-PD-1 blockade in microsatellite stable-type murine colorectal cancer cells.
Journal: American journal of cancer research
Published: August 28, 2017
Combined efficacy and mechanism of trifluridine and SN-38 in a 5-FU-resistant human colorectal cancer cell lines.
Journal: American journal of cancer research
Published: August 21, 2017
5-Chloro-2,4-dihydroxypyridine, CDHP, prevents lung metastasis of basal-like breast cancer cells by reducing nascent adhesion formation.
Journal: Cancer medicine
Published: August 09, 2017
Last Updated: 09/26/2026